MENU
CGEM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cullinan Therapeutics (CGEM) Ownership - Who owns Cullinan Therapeutics?
Profile
Industry
N/A
Address
One Main Street
Phone
+1 617 410-4650
Employees
85
Web
https://www.cullinanoncology.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
669.04M
P/E Ratio
N/A
Total Cash
578.08M
Projected Growth
N/A
Total Debt
2.45M
Revenue
N/A
Risk (Beta)
-0.21
Dividend Yield
N/A
Total Cash/Share
9.93
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CGEM
Capitalization
669M
P/E Ratio
N/A
Risk (Beta)
-0.21
Dividend Yield
N/A
Total Cash
578M
Total Cash/Share
9.93
Total Debt
2.45M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
628M
P/B Ratio
1.07
Cash Flow
N/A
Earnings
-2.84
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
24.46
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-187.05M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-25.01
Shares Held By Institutions
1.37B
Shares Outstanding - Current
58.2M
Total Liabilities
25.4M
Total Volume MTD
N/A
Value
N/A
Gain YTD
12.758
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
One Main Street
Phone
+1 617 410-4650
Employees
85
Web
https://www.cullinanoncology.com